About Us
WONZ Technology is a digital health company dedicated to harm reduction in S and nicotine addiction therapy. Throughout history, TB combustion and consumption have posed significant risks to human health. However, existing S cessation medications and methods still face challenges, such as low compliance and high relapse rates. One of the primary reasons is the addictive nature of nicotine, which leads to withdrawal symptoms. Therefore, by dividing the TB cessation process into stages, better compliance and success rates in quitting S can be achieved through the steps of harm reduction, S control, and scientific cessation, without introducing new alternative products.
Following these principles, WONZ Technology combines nicotine replacement therapy with innovative technologies, including distillation separation technology , efficient filtration techniques, and psychological intervention methods. They have successfully reduced over 90% of more than 20 major harmful components in TB S. Users do not need to endure the suffering of withdrawal symptoms, yet they can achieve harm reduction effects similar to S cessation, thereby providing protection for themselves and family members. WONZ Technology has invested millions of dollars and undergone three years of research and development to launch various digital health devices and software, including the WONZ harm reduction smart device, the WONZ portable TB addiction tester, digital intervention software, and COPD intervention therapy, to address nicotine addiction and related health issues.
WONZ Technology has been identified as a National High and New Tech Enterprise and Specialized, High-End, and Innovation-Driven SME, holding over 100 patents, the majority of which are invention and utility model patents. In 2022, an RCT study confirmed the clinical effectiveness of WONZ's comprehensive therapy, which significantly reduced exposure to harmful substances in S' bodies and alleviated S cravings, among other key indicators. The results of this study will be submitted for publication in professional medical journals, and WONZ is also in the process of applying for NMPA device certification for their related products.You can contact us by (+86）18600872875
2020
Mr. Du Xin, the founder of WONZ, felt the pure nicotine aroma released by cured tobacco in the laboratory for the first time. Since then, an alternative health solution for the 1.5 billion smokers around the world has quietly sprouted in his mind. In the same year, WONZ Technology was established.
2021
The functions of the device have been comprehensively upgraded, and the heat insulation and heating functions of the product have been improved. In particular, the material of the product has been further updated and iterated.
2022
Cooperated with many service providers including MORPHEUS to expand online sales channels and obtained tens of millions of financing from XVC and other institutions. Apply for WHC (WONZ Heat Currents) heat rise technology, intelligent precision temperature control technology (error ±1 °C), high-efficiency filtration adsorption technology and many other technical patents.
2023
The number of patent applications for WONZ Technology exceeded 111 and was listed in the "POC50·Top 50 Startup Companies with the Most Proof-of-Concept Capability" list.
2024
WONZ Technology adheres to its original intention of providing health solutions to smokers around the world, and sets clear annual goals for the company to move forward.